An antibody targets a tumor-associated antigen, the conjugate is internalized, its linker is cleaved, and a potent cytotoxic payload is released within the cancer cell to cause cell death (e.g., via DNA damage or microtubule disruption), with potential bystander effect depending on linker/payload.